Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Fletcher currently holds 15,821,836 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Fletcher has been a net seller of GNBT stock. They have purchased $27.7K and sold $262.9K worth of shares.
Mark Fletcher's most recent insider trade was on Feb 16, 2016, when they sold 4,447,111 shares at $0.00 per share.
Mark Fletcher serves as Executive at GENEREX BIOTECHNOLOGY CORP (GNBT). They have executed 14 insider transactions totaling $290.6K over their tenure at the company.
Mark Fletcher holds the position of Executive at GENEREX BIOTECHNOLOGY CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark Fletcher has shown a selling trading pattern, with $27.7K in total purchases and $262.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Fletcher was on Apr 18, 2008, when they sold $222.5K worth of GNBT shares. This transaction involved 250,000 shares at $0.89 per share.
Mark Fletcher currently owns 15,821,836 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Fletcher's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Fletcher has 14 Form 4 filings on record as an insider at GENEREX BIOTECHNOLOGY CORP.
Set alerts for Mark Fletcher and 40,000+ other insiders.